Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 13, 2025

Skye Bioscience Clinical Model Demonstrating Necessity of Peripheral CB1 Inhibition for Weight Loss Presented at European Congress on Obesity
• This model demonstrates that central inhibition of CB1 is not required for weight loss • Anti-CB1 inhibiting antibody, nimacimab, showed greatest peripheral restriction compared with monlunabant and rimonabant, small molecule-based CB1 inhibitors, which …

Study finds BILT for Apple Vision Pro accelerates training
GRAPEVINE, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- BILT Incorporated, creators of 3D Intelligent Instructions®, confirms findings of a case study that evaluated the impact of spatial computing and extended reality (XR) content on trade school students. …

GenVivo Highlights GEN2 Phase 1 Data and GEN-1013 Preclinical Data at the 2025 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting
GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and expansion trial. GEN-1013 was studied in aggressive murine cancer models using both IV and IT administration; prolonged survival, …

Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights
Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Cash, cash equivalents and marketable securities of $197.9 million as of March 31, 2025, …

Y-mAbs Reports First Quarter 2025 Financial Results and Recent Corporate Developments
Reported Net Product Revenues of $20.9 million for the first quarter of 2025, a year-over-year increase of approximately 8% National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Neuroblastoma updated to include …

Arbor Biotechnologies to Present Preclinical Data for ABO-101 in PH1 at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
– Data from oral presentation supported ABO-101 IND and CTA approval for clinical assessment in primary hyperoxaluria type 1 (PH1) in the Phase 1/2 redePHine study in US and UK (NCT06839235) – Preclinical data demonstrate highly specific and durable …

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
~ Achieved First Quarter 2025 Total Net Revenues of $8.8 Million, Up 18% Year Over Year ~ ~ Positive Momentum from Company’s Refined, Targeted Sales Strategy and Enhanced Patient Support Services ~ ~ PEDMARQSI Now Commercially Available in Germany and the …

Sophos Accelerates Business Growth and Profitability for MSPs with the Launch of MSP Elevate Program
OXFORD, United Kingdom, May 13, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating cyberattacks, today launched MSP Elevate, a new business-accelerating program for managed service providers (MSPs). With the new …

Ring Therapeutics Presents New Data on its AnelloBricks® Manufacturing Platform at the 28th Annual American Society of Gene & Cell Therapy Conference
AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic advantages in manufacturing scalability and cost compared to existing vector systems Payload versatility of AnelloVectors® widens the …

Fortuna Completes Divestiture of Yaramoko Mine and Provides Updated 2025 Production and Cost Guidance
VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) (“Fortuna” or the “Company”) is pleased to announce the successful completion of the sale of its interest in Roxgold Sanu SA (“Roxgold Sanu”), …

EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025 EBX-102 was well tolerated and showed multiple positive trends over placebo Findings support progression to a Phase 2b trial Glasgow, Scotland – 13 May 2025. EnteroBiotix Limited (‘ …

Amperfied Selects Lumissil’s CG5317 Green PHY for New DC Fast Charging System
MILPITAS, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Lumissil, a leading provider of advanced automotive connectivity solutions, announced that Amperfied has selected the CG5317 Green PHY modem for their latest DC charging product. Amperfied, a subsidiary of …

STACK Infrastructure Closes $1.4 Billion in Green Financing to Support its Growing Portfolio of Stabilized Hyperscale Assets
DENVER, May 13, 2025 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to the world’s most innovative companies and a leading global developer and operator of data centers, today announced the successful closing of a $1 …

2024 Exploration Update for Strategic Minerals JV
Reykjavík, May 13, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) 2024 Exploration Update for Strategic Minerals JV Amaroq Advances its Strategic Minerals Vision — Welcoming Dr. Steve Garwin TORONTO, ONTARIO – May 13, 2025 – …

Bitget Announces Strategic Partnership with SWEAT to Boost Movement Economy in Web3
Dubai, UAE, May 9th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced its strategic partnership with SWEAT, the pioneering movement economy ecosystem, lowering entry barriers for Web2 audiences while seamlessly …

Bitget lists Doodles (DOOD) for Spot Trading
Victoria, Seychelles, May 9th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Doodles ($DOOD), adding it to spot trading. Doodles is an on-chain collective that creates worlds and claims to …

From Ashes to Action: OptiCloud Turns Digital and Energy Waste into Climate Action
Image courtesy of Vijay Karia/OptiCloud NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- In January 2025, Los Angeles experienced one of the most catastrophic wildfire events in its history. The Palisades and Eaton fires, fueled by extreme weather conditions and …

EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy, with international trial site in Singapore to follow
First Patient dosed in Phase I/IIa Basket Trial for Solid Tumours at Mater Hospital, North Sydney Recruitment to open this month at Frankston Hospital, Victoria Further site to follow at Curie Oncology, Singapore SYDNEY, May 12, 2025 (GLOBE NEWSWIRE) -- …

Prime Mining Reports Q1 2025 Financial and Operating Results
VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSV: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) is pleased to report its operating and financial results for the quarter ended March 31, 2025. Prime is …